Barbara Willekens, EAN 2022: Predictors of disease progression and outcome in multiple sclerosis – Highlights
Cognitive impairment can predict physical disability progression in multiple sclerosis (MS). It was a pleasure to speak with Dr Barbara Willekens (Antwerp University Hospital, Edegem, Belgium), who talked through some of the presentations given in this EAN 2022 session on predictors and outcomes in MS and related disorders.
Questions:Â
- How does cognitive impairment predict physical disability progression in multiple sclerosis (MS)? (00:22)
- What are predictors and outcomes for MS emergency admissions? (01:47)
- What are your thoughts on the potential new outcome, disability improvement in MS patients? (03:47)
- What is brain age in MS? (05:37)
The session titled, ‘MS and related disorders: Predictors for MS outcome‘ took place at the European Academy of Neurology Congress 2022, 25–28 June 2022.
Disclosure: Barbara Willekens has served as a consultant for Almirall, Biogen, BMS-Celgene, Janssen, Merck, Novartis, Roche and Sandoz; received grant/reasearch support from Biogen, Research Fund Flanders, Charcot Foundation Belgium, Merck, Sanofi-Genzyme and Roche; and participated in advisory boards for Almirall, Biogen, BMS-Celgene, Janssen, Merck, Novartis, Roche and Sandoz.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Lisa Glass.
Filmed as a highlight of EAN 2022.
